| 查看: 6653 | 回复: 32 | |||
[交流]
埃索美拉唑钠 药典标准
|
|||
|
埃索美拉唑钠 有没有药典标准呀 一直没找到... 没有的话，自己生产的话这标准是参考 埃索美拉唑镁 还是 奥美拉唑钠 |
回复此楼» 本帖已获得的红花（最新10朵）
» 猜你喜欢
一篇扩散模型的Nature Machine Intelligence论文和Elsevier上的深度学习药物书籍
已经有1人回复
-
中国药科大学2026入学博士，药物合成和设计经验，放射化学及放射医学研究
已经有25人回复
-
药物学论文润色/翻译怎么收费?
已经有258人回复
-
使用MolAICal进行多肽虚拟筛选教程-同样适用于蛋白质和核酸的虚拟筛选
已经有1人回复
-
使用MolAICal计算药物化学过滤器MCFs及MCE-18描述符
已经有0人回复
-
使用MolAICal发现蛋白受体潜在的活性口袋及位点
已经有0人回复
-
华理药学学硕求调剂，总分324
已经有0人回复
-
广西医科大学基础医学院自身免疫病课题组招收基础医学相关专业的调剂研究生
已经有2人回复
-
澳门理工大学人工智能药物发现中心招收2026级博士研究生（申请-考核制）
已经有10人回复
-
广西医科大学基础医学院招收基础医学、药学、生物检验相关专业的研究生
已经有1人回复
» 本主题相关价值贴推荐，对您同样有帮助:
- 埃索美拉唑钠原料的开发
已经有16人回复
- 埃索美拉唑钠的重结晶方法
已经有18人回复
- 求助埃索美拉唑钠的研发背景资料
已经有8人回复
- 埃索美拉唑镁肠溶微丸释放时变色
已经有13人回复
- 大家有没有做埃索美拉唑钠项目的进来交流一下！
已经有47人回复
- 【求助】高手请进 关于埃索美拉唑钠盐的紫外图谱
已经有8人回复
- 【求助】埃索美拉唑钠
已经有17人回复
» 抢金币啦！回帖就可以得到:
-
工科男，工作稳定，希望能遇到有趣的她
+1/169
-
有能报销版面费的老师合作发表SCI开源期刊吗？
+1/87
-
山东大学深地储能系统工程课题组常年招聘优秀博士后研究人员
+1/84
-
北京邮电大学电子科学与技术招收博士
+1/29
-
坐标北京，83年男征女友
+1/26
-
天津大学 合成生物技术全国重点实验室 国家级青年人才团队常年招收博士后
+1/19
-
中国农业大学资源与环境学院 - 招聘杰出人才、青年研究员、优秀人才和博士后
+1/13
-
港科大广州 - 量子计算全奖PhD招生
+1/11
-
类器官/器官芯片 有编制研究员
+1/11
-
吉林大学任雷课题组招机器人和触觉传感方向2026年入学博士生
+1/9
-
深圳大学材料学院“智能分子材料团队”招聘博士后（连续流微反应器方向优先）
+1/9
-
【硕士生补录】澳科大诚招2026年秋季药剂学硕士研究生1-2名
+1/5
-
注册小木虫周年大礼包
+1/5
-
成都中医药大学药学院 谢恬教授招收2026级药物化学，有机合成方向的博士生
+1/4
-
招收2026年秋季入学博士生1名（河北工业大学/北京科技大学联合 增材制造/生物材料）
+1/3
-
英国伦敦布鲁内尔大学高薪招聘欧盟玛丽居里全奖博士
+1/3
-
UIO-66-NH2/RGO如何碳化，求助！！！！！
+1/3
-
【急招】北京航空航天大学 | 超声脑机接口方向 | 2026年博士研究生
+1/3
-
爱思维尔旗下LWT投稿
+1/2
-
天津医科大学基础医学院基础医学院2026级博士招生
+1/2
2楼2011-08-30 14:35:50
★
hao8431(金币+1):谢谢参与
hao8431(金币+1):谢谢参与
|
以下是USP34版友原料药镁盐的标准 Esomeprazole Magnesium (es'' oh mep' ra zole mag nee' zee um). C34H36MgN6O6S2·3H2O Trihydrate: 767.17 C34H36MgN6O6S2 Anhydrous: 713.12 1H-Benzimidazole,5-methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl], magnesium salt (2:1), trihydrate; 5-Methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]benzimidazole, magnesium salt (2:1), trihydrate [217087-09-7]. DEFINITION Esomeprazole Magnesium contains NLT 98.0% and NMT 102.0% of C34H36MgN6O6S2, calculated on the anhydrous basis. IDENTIFICATION • A. INFRARED ABSORPTION 197K • B. The Sample solution, prepared and tested as directed in the test for Content of Magnesium, exhibits a significant absorption at 285.2 nm. ASSAY • PROCEDURE Solution A: Dissolve 0.725 g of monobasic sodium phosphate and 4.472 g of anhydrous dibasic sodium phosphate in 300 mL of water, and dilute with water to 1000 mL. Dilute 250 mL of this solution with water to 1000 mL. If necessary, adjust with phosphoric acid to a pH of 7.6. Solution B: Mix 11 mL of 0.25 M tribasic sodium phosphate with 22 mL of 0.5 M dibasic sodium phosphate, and dilute with water to 100 mL. Mobile phase: Acetonitrile and Solution A (7:13) Standard solution: Transfer 10 mg of USP Omeprazole RS to a 200-mL volumetric flask, and dissolve in about 10 mL of methanol. Add 10 mL of Solution B, and dilute with water to volume. [NOTE—This solution contains 0.05 mg/mL of omeprazole. ] Sample solution: Transfer 10 mg of Esomeprazole Magnesium to a 200-mL volumetric flask, and dissolve in about 10 mL of methanol. Add 10 mL of Solution B, and dilute with water to volume. [NOTE—This solution contains 0.05 mg/mL of esomeprazole magnesium. ] Chromatographic system (See Chromatography 621 , System Suitability.) Mode: LC Detector: UV 280 nm Column: 4.0-mm × 12.5-cm or a 4.6-mm × 15-cm; 5-μm packing L7. [NOTE— Alternatively, a 3.9-mm × 15-cm column that contains 4-μm packing L1 may be used. ] Flow rate: 1 mL/min Injection size: 20 μL System suitability Sample: Standard solution Suitability requirements Column efficiency: NLT 2000 theoretical plates Relative standard deviation: NMT 2.0% Analysis Samples: Standard solution and Sample solution Calculate the percentage of C34H36MgN6O6S2 in the portion of Esomeprazole Magnesium taken: Result = (rU/rS) × (CS/CU) × [Mr1/(2 × Mr2)] × 100 Acceptance criteria: 98.0%–102.0% on the anhydrous basis OTHER COMPONENTS • CONTENT OF MAGNESIUM Lanthanum solution: Transfer 58.7 g of lanthanum oxide into a 1000-mL volumetric flask, wet the substance with some water, and dissolve by cautious addition of 250 mL of hydrochloric acid in 20- to 30-mL portions, cooling between the additions. Add water while stirring, cool to room temperature, and dilute with water to volume. [NOTE—Store the solution in a plastic bottle. ] Standard stock solution: 1000 μg/mL of magnesium in water, from a commercially prepared atomic absorption standard solution. [NOTE—Store the solution in a plastic bottle. ] Standard solution A: Transfer 10.0 mL of Standard stock solution to a 500-mL volumetric flask, add 50 mL of 1 N hydrochloric acid, and dilute with water to volume. Transfer 20.0 rU = = peak response from the Sample solution rS = = peak response from the Standard solution CS = = concentration of omeprazole in the Standard solution (mg/mL) CU = = concentration of Esomeprazole Magnesium in the Sample solution (mg/mL) Mr1 = = molecular weight of esomeprazole magnesium, 713.12 Mr2 = = molecular weight of omeprazole, 345.42 mL of this solution to a 200-mL volumetric flask, and dilute with water to volume. [NOTE— This solution contains 2 μg/mL of magnesium. ] Standard solution B: Combine 5.0 mL of Standard solution A and 4.0 mL of Lanthanum solution, and dilute with water to 100.0 mL (0.1 μg/mL). Standard solution C: Combine 10.0 mL of Standard solution A and 4.0 mL of Lanthanum solution, and dilute with water to 100.0 mL (0.2 μg/mL). Standard solution D: Combine 15.0 mL of Standard solution A and 4.0 mL of Lanthanum solution, and dilute with water to 100.0 mL (0.3 μg/mL). Standard solution E: Combine 20.0 mL of Standard solution A and 4.0 mL of Lanthanum solution, and dilute with water to 100.0 mL (0.4 μg/mL). Standard solution F: Combine 25.0 mL of Standard solution A and 4.0 mL of Lanthanum solution, and dilute with water to 100.0 mL (0.5 μg/mL). [NOTE—Concentrations of the Standard solutions and the Sample solution may be modified to fit the linear or working range of the instrument. When using instruments with a linear calibration graph, the number of Standard solutions can be reduced. ] Blank solution: Transfer 4.0 mL of Lanthanum solution to a 100-mL volumetric flask, and dilute with water to volume. Sample solution: Transfer 250 mg of Esomeprazole Magnesium to a 100-mL volumetric flask, add 20 mL of 1 N hydrochloric acid, swirl until dissolved, and dilute with water to volume. Allow to stand for 30 min. Transfer 10.0 mL of this solution to a 200-mL volumetric flask, and dilute with water to volume. Transfer 10.0 mL of the solution to another 100-mL volumetric flask, add 4.0 mL of Lanthanum solution, and dilute with water to volume. Spectrometric conditions (See Spectrophotometry and Light-Scattering 851 .) Mode: Atomic absorption spectrophotometer Flame: Air–acetylene Analytical wavelength: 285.2 nm Analysis Samples: Standard solution B, Standard solution C, Standard solution D, Standard solution E, Standard solution F, Blank solution, and Sample solution Determine the concentration, Cs, in μg/mL, of magnesium in the Sample solution using the calibration graph. Calculate the percentage of magnesium in the portion of Esomeprazole Magnesium taken: Result = (CS/CU) × (100/(100 F)) × 100 CS = = content of magnesium in the Sample solution as calculated above (μg/mL) CU = = concentration of Esomeprazole Magnesium in the Sample solution (μg/mL) F = = content of water in Esomeprazole Acceptance criteria: 3.30%–3.55%, on anhydrous basis IMPURITIES Organic Impurities • PROCEDURE 1 Solution A: 0.725 g of monobasic sodium phosphate and 4.472 g of anhydrous dibasic sodium phosphate in 300 mL of water, and dilute with water to 1000 mL. Dilute 250 mL of this solution with water to 1000 mL. If necessary, adjust with phosphoric acid to a pH of 7.6. Mobile phase: Acetonitrile and Solution A (11:29). [NOTE—To improve the resolution, the composition may be changed to 1:3, if necessary. ] System suitability solution: 1 mg of USP Omeprazole RS and 1 mg of USP Omeprazole Related Compound A RS in 25 mL of Mobile phase. [NOTE—Omeprazole Related Compound A is omeprazole sulfone. ] Sample solution: 4 mg of Esomeprazole Magnesium in 25 mL of Mobile phase. [NOTE— Prepare this solution fresh. ] Chromatographic system (See Chromatography 621 , System Suitability.) Mode: LC Detector: UV 280 nm Column: 4.0-mm × 12.5-cm or a 4.6-mm × 15-cm; 5-μm packing L7. [NOTE— Alternatively, a 3.9-mm × 15-cm column that contains 4-μm packing L1 may be used. ] Flow rate: 0.8–1 mL/min Injection size: 50 μL System suitability Sample: System suitability solution [NOTE—For relative retention times, see Impurity Table 1. ] Suitability requirements Resolution: NLT 3 between omeprazole related compound A and omeprazole Analysis Sample: Sample solution Record the chromatogram for at least 4.5 times the retention time of the omeprazole peak, and measure the peak responses. Identify the impurities based on the retention times shown in Impurity Table 1. Calculate the percentage of any individual impurity in the portion of Esomeprazole Magnesium taken: Result = (rU/rT) × 100 Magnesium, as determined in Specific Tests, Water Determination (%) rU = = peak response for each impurity = = sum of all peak responses Acceptance criteria Individual impurities: See Impurity Table 1. Total impurities: NMT 0.5% Impurity Table 1 • PROCEDURE 2: ENANTIOMERIC PURITY Solution A: Mix 70 mL of 1 M monobasic sodium phosphate with 20 mL of 0.5 M dibasic sodium phosphate, and dilute with water to 1000 mL. Dilute 250 mL of this solution with water to 1000 mL. Diluent: Mix 11 mL of 0.25 M tribasic sodium phosphate with 22 mL of 0.5 M dibasic sodium phosphate, and dilute with water to 1000 mL. Mobile phase: Acetonitrile and Solution A (3:17) System suitability solution: 2 mg of USP Omeprazole RS in 10 mL of Diluent. Dilute 1.0 mL of this solution with Diluent to 50 mL. Sample solution: 40 mg of Esomeprazole Magnesium in 5 mL of methanol, and dilute with Diluent to 25 mL. Dilute 1 mL of this solution with Diluent to 50 mL. Chromatographic system (See Chromatography 621 , System Suitability.) Mode: LC Detector: UV 302 nm Column: 4.0-mm × 10-cm; packing L41 Flow rate: 0.6 mL/min Injection size: 20 μL System suitability Sample: System suitability solution Suitability requirements Resolution: NLT 3 between the enantiomer peaks. [NOTE—The elution order is the Renantiomer, followed by the esomeprazole peak, which is the S-enantiomer. ] Analysis rT Name Relative Retention Time Acceptance Criteria, NMT (%) Omeprazole N-oxide a 0.45 0.1 Omeprazole sulfoneb (related compound A) 0.8 0.2 Any other individual impurities — 0.1 Omeprazole 1.0 — a 4-Methoxy-2-[[(RS)-(5-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-3,5- dimethylpyridine 1-oxide. b 5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfonyl]-1Hbenzimidazole. Sample: Sample solution Calculate the percentage of the R-enantiomer in the portion of Esomeprazole Magnesium taken: Result = (rU/rS) × 100 Acceptance criteria: NMT 0.2% of the R-enantiomer SPECIFIC TESTS • WATER DETERMINATION, Method I 921 : 6.0%–8.0% • COLOR OF SOLUTION Sample solution: 20 mg/mL of Esomeprazole Magnesium in methanol Analysis: Determine the absorbance of this solution at 440 nm, in 1-cm cells, using methanol as the blank. Acceptance criteria: NMT 0.2 ADDITIONAL REQUIREMENTS • PACKAGING AND STORAGE: Preserve in tight containers, protected from light. Store at room temperature. • USP REFERENCE STANDARDS 11 USP Esomeprazole Magnesium RS USP OMEPRAZOLE RS USP OMEPRAZOLE RELATED COMPOUND A RS Omeprazole sulfone, 5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfonyl]- 1H-benzimidazole. C17H19N3O4S 361.42 [CAS-88546-55-8]. Auxiliary Information— Please check for your question in the FAQs before contacting USP. USP34–NF29 Page 2741 Pharmacopeial Forum: Volume No. 35(3) Page 550 Chromatographic Column— ESOMEPRAZOLE MAGNESIUM rU = = peak response for the R-enantiomer rS = = sum of the peak responses for esomeprazole and R-enantiomer Topic/Question Contact Expert Committee Monograph Elena Gonikberg, Ph.D. Principal Scientific Liaison 1-301-816-8251 (SM32010) Monographs - Small Molecules 3 Reference Standards RS Technical Services 1-301-816-8129 rstech@usp.org Chromatographic columns text is not derived from, and not part of, USP 34 or NF 29 还有EP7.0里面是三水合物的标准，如果需要可以联系我，或留下邮箱我把标准发给你！ |
3楼2011-08-30 14:44:06
4楼2011-08-30 14:50:28
5楼2011-08-30 14:55:54
6楼2011-08-30 16:55:21
7楼2011-08-31 09:20:09
8楼2011-08-31 09:35:01
9楼2011-08-31 11:26:56
10楼2011-08-31 11:31:06
15楼2011-08-31 12:11:38
16楼2011-08-31 16:26:54
17楼2011-11-03 16:02:11
18楼2012-01-04 10:20:25
19楼2012-01-04 11:24:16
20楼2012-01-19 15:17:09
21楼2012-01-19 19:24:40
22楼2012-01-19 19:24:52
23楼2012-01-19 19:25:10
24楼2012-01-20 18:55:18
25楼2012-01-20 21:28:30
26楼2012-02-17 17:25:55
28楼2012-04-13 14:19:40
需要进口标准 29楼2012-05-28 16:06:36
30楼2012-08-24 09:29:26
31楼2016-01-15 16:59:41
 本帖仅楼主可见 |
32楼2019-08-23 17:13:56
★
小木虫: 金币+0.5, 给个红包，谢谢回帖
送红花一朵
emuch: 屏蔽内容, 违规存档, 违规发布联系方式 2019-08-28 09:49:36
小木虫: 金币+0.5, 给个红包，谢谢回帖
送红花一朵emuch: 屏蔽内容, 违规存档, 违规发布联系方式 2019-08-28 09:49:36
|
本帖内容被屏蔽 |
33楼2019-08-28 09:17:24
简单回复
ly20112011a11楼
2011-08-31 11:42
回复
hao8431(金币+1):谢谢参与
xiaocui198712楼
2011-08-31 11:56
回复
hao8431(金币+1):谢谢参与
xiaocui198713楼
2011-08-31 11:56
回复
hao8431(金币+1):谢谢参与
xiaocui198714楼
2011-08-31 11:59
回复
hao8431(金币+1):谢谢参与
豆芽小笨熊27楼
2012-02-17 23:33
回复